Cargando…

Posttranslational Modifications of Red Blood Cell Ghost Proteins as “Signatures” for Distinguishing between Low- and High-Risk Myelodysplastic Syndrome Patients

Detalles Bibliográficos
Autores principales:	Pecankova, Klara, Majek, Pavel, Cermak, Jaroslav, Dyr, Jan E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2017
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451676/ https://www.ncbi.nlm.nih.gov/pubmed/27610705 http://dx.doi.org/10.4274/tjh.2016.0251

Ejemplares similares

Peripheral Blood Mononuclear Cell Proteome Changes in Patients with Myelodysplastic Syndrome
por: Pecankova, Klara, et al.
Publicado: (2015)

Plasma Protein Biomarker Candidates for Myelodysplastic Syndrome Subgroups
por: Majek, Pavel, et al.
Publicado: (2015)

Proteome Changes in the Plasma of Myelodysplastic Syndrome Patients with Refractory Anemia with Excess Blasts Subtype 2
por: Majek, Pavel, et al.
Publicado: (2014)

Plasma proteome changes associated with refractory anemia and refractory anemia with ringed sideroblasts in patients with myelodysplastic syndrome
por: Májek, Pavel, et al.
Publicado: (2013)

Proteomic Case Studies of MDS in Progression: Heterogeneity and More Heterogeneity
por: Pecankova, Klara, et al.
Publicado: (2022)

Proteome changes of plasma-derived extracellular vesicles in patients with myelodysplastic syndrome
por: Pecankova, Klara, et al.
Publicado: (2022)

Plasma protein alterations in the refractory anemia with excess blasts subtype 1 subgroup of myelodysplastic syndrome
por: Májek, Pavel, et al.
Publicado: (2012)

Impact of posttranslational modifications on atomistic structure of fibrinogen
por: Sovová, Žofie, et al.
Publicado: (2020)

Improved Coomassie Blue Dye-Based Fast Staining Protocol for Proteins Separated by SDS-PAGE
por: Májek, Pavel, et al.
Publicado: (2013)

Enhanced levels of asymmetric dimethylarginine in a serum of middle age patients with myelodysplastic syndrome
por: Štikarová, Jana, et al.
Publicado: (2013)

Plasma proteome changes in cardiovascular disease patients: novel isoforms of apolipoprotein A1
por: Májek, Pavel, et al.
Publicado: (2011)

Plasma proteome changes associated with refractory cytopenia with multilineage dysplasia
por: Májek, Pavel, et al.
Publicado: (2011)

Extension of the Human Fibrinogen Database with Detailed Clinical Information—The αC-Connector Segment
por: Sovova, Zofie, et al.
Publicado: (2021)

Plasma Levels of Aminothiols, Nitrite, Nitrate, and Malondialdehyde in Myelodysplastic Syndromes in the Context of Clinical Outcomes and as a Consequence of Iron Overload
por: Pimková, Kristýna, et al.
Publicado: (2014)

A New Approach for the Diagnosis of Myelodysplastic Syndrome Subtypes Based on Protein Interaction Analysis
por: Chrastinová, Leona, et al.
Publicado: (2019)

Posttranslational Modifications in Ferroptosis
por: Wei, Xiang, et al.
Publicado: (2020)

HBprem: A database of transcription, translation, and posttranscriptional and posttranslational modifications in hepatoblastoma
por: Song, Hang, et al.
Publicado: (2020)

PHYSIOLOGICAL CHARACTERISTICS OF HUMAN RED BLOOD CELL GHOSTS
por: Hoffman, Joseph F.
Publicado: (1958)

Posttranslational modification and microtubule stability
Publicado: (1987)

Posttranslational Modifications and the Immunogenicity of Biotherapeutics
por: Jefferis, Roy
Publicado: (2016)

Posttranslational modifications in pathogenesis of PCOS
por: Wei, Huimei, et al.
Publicado: (2022)

Posttranslational Chemical Mutagenesis Methods to Insert Posttranslational Modifications into Recombinant Proteins
por: Harel, Omer, et al.
Publicado: (2022)

Posttranslational modification of proteins : expanding nature's inventory /
por: Walsh, Christopher
Publicado: (2006)

The Active Transport of Sodium by Ghosts of Human Red Blood Cells
por: Hoffman, Joseph F.
Publicado: (1962)

Regulation of Sirtuin Function by Posttranslational Modifications
por: Flick, Franziska, et al.
Publicado: (2012)

PHOSIDA 2011: the posttranslational modification database
por: Gnad, Florian, et al.
Publicado: (2011)

Posttranslational Processing and Modification of Cathepsins and Cystatins
por: Katunuma, Nobuhiko
Publicado: (2010)

Dynamics of Posttranslational Modifications of p53
por: Fan, Qing-Duan, et al.
Publicado: (2014)

Posttranslational modification of a vanadium nitrogenase
por: Heiniger, Erin K, et al.
Publicado: (2015)

Autoantibodies to Posttranslational Modifications in Rheumatoid Arthritis
por: Burska, Agata N., et al.
Publicado: (2014)

Posttranslational Modification of Intercellular Messenger Systems
por: Kakizawa, Sho, et al.
Publicado: (2014)

Posttranslational modifications of proteins in diseased retina
por: Starr, Christopher R., et al.
Publicado: (2023)

THE BIREFRINGENCE OF THE HUMAN RED CELL GHOSTS
por: Ponder, Eric, et al.
Publicado: (1956)

Posttranslational modifications of blood-derived alpha-synuclein as biochemical markers for Parkinson’s disease
por: Vicente Miranda, Hugo, et al.
Publicado: (2017)

G6PD deficiency in the COVID-19 pandemic: Ghost within Ghost
por: Al-Abdi, Sameer, et al.
Publicado: (2021)

Slow posttranslational modification of a neurofilament protein
Publicado: (1985)

Archaeal Protein Biogenesis: Posttranslational Modification and Degradation
por: Eichler, Jerry, et al.
Publicado: (2010)

Posttranslational Modifications of Ribosomal Proteins in Escherichia coli
por: Nesterchuk, M.V., et al.
Publicado: (2011)

Chemical and Functional Aspects of Posttranslational Modification of Proteins
por: Knorre, D.G., et al.
Publicado: (2009)

The Role of PCNA Posttranslational Modifications in Translesion Synthesis
por: Shaheen, Montaser, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_h5ar27eaoej9h762hq07qk4r7c